Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ACAB | Series A Common Stock, par value $0.0001 per share | Options Exercise | +50K | 50K | Apr 18, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ACAB | Series B Common Stock, par value $0.0001 per share | Options Exercise | -50K | -100% | 0 | Apr 18, 2023 | Series A Common Stock, par value $0.0001 per share | 50K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | On April 18, 2023 the Reporting Person elected to exercise their right to convert 50,000 shares of Series B Common Stock into 50,000 shares of Series A Common Stock. |
F2 | The Series B Common Stock are convertible into the Issuer's Series A Common Stock on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights, as described under the heading "Description of Securities-Common Stock" in the Issuer's registration statement on Form S-1 (File No. 333-261459) and the Issuer's DEF 14A filed March 20th, 2023 and have no expiration date. |